Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ploug

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Acta Crystallographica. Section F, Structural Biology Communications|August 5, 2017
Expression and crystallographic studies of the D1D2 domains of C4.4A, a homologous protein to the urokinase receptorShanli Chen, Lin Lin, Cai Yuan, et al.
The Journal of Biological Chemistry|July 30, 2011
Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia inductionHenrik Gårdsvoll, Benedikte Jacobsen, Mette C Kriegbaum, et al.
Molecular Pharmaceutics|June 24, 2014
uPAR targeted radionuclide therapy with (177)Lu-DOTA-AE105 inhibits dissemination of metastatic prostate cancerMorten Persson, Karina Juhl, Palle Rasmussen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPETZi-Bo Li, Gang Niu, Hui Wang, et al.
The Journal of Biological Chemistry|March 21, 2006
A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growthPratima Chaurasia, Julio A Aguirre-Ghiso, Olin D Liang, et al.
Thrombosis and Haemostasis|April 21, 2005
Plasminogen activation and cancerKeld Danø, Niels Behrendt, Gunilla Høyer-Hansen, et al.
The Journal of Biological Chemistry|May 5, 2006
Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linkingHenrik Gårdsvoll, Bernard Gilquin, Marie Hélène Le Du, et al.
Chemmedchem|October 27, 2020
Small-Molecule Inhibition of the uPAR ⋅ uPA Interaction by Conformational SelectionDavid Xu, Khuchtumur Bum-Erdene, Julie M Leth, et al.
Clinical Chemistry|September 4, 2004
Specific immunoassays for detection of intact and cleaved forms of the urokinase receptorTimo Piironen, Birgitte Laursen, Jesper Pass, et al.
Theranostics|September 21, 2013
Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studiesMorten Persson, Masood Hosseini, Jacob Madsen, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Acta Crystallographica. Section F, Structural Biology Communications|August 5, 2017
Expression and crystallographic studies of the D1D2 domains of C4.4A, a homologous protein to the urokinase receptorShanli Chen, Lin Lin, Cai Yuan, et al.
The Journal of Biological Chemistry|July 30, 2011
Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia inductionHenrik Gårdsvoll, Benedikte Jacobsen, Mette C Kriegbaum, et al.
Molecular Pharmaceutics|June 24, 2014
uPAR targeted radionuclide therapy with (177)Lu-DOTA-AE105 inhibits dissemination of metastatic prostate cancerMorten Persson, Karina Juhl, Palle Rasmussen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPETZi-Bo Li, Gang Niu, Hui Wang, et al.
The Journal of Biological Chemistry|March 21, 2006
A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growthPratima Chaurasia, Julio A Aguirre-Ghiso, Olin D Liang, et al.
Thrombosis and Haemostasis|April 21, 2005
Plasminogen activation and cancerKeld Danø, Niels Behrendt, Gunilla Høyer-Hansen, et al.
The Journal of Biological Chemistry|May 5, 2006
Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linkingHenrik Gårdsvoll, Bernard Gilquin, Marie Hélène Le Du, et al.
Chemmedchem|October 27, 2020
Small-Molecule Inhibition of the uPAR ⋅ uPA Interaction by Conformational SelectionDavid Xu, Khuchtumur Bum-Erdene, Julie M Leth, et al.
Clinical Chemistry|September 4, 2004
Specific immunoassays for detection of intact and cleaved forms of the urokinase receptorTimo Piironen, Birgitte Laursen, Jesper Pass, et al.
Theranostics|September 21, 2013
Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studiesMorten Persson, Masood Hosseini, Jacob Madsen, et al.
Pageof 13